Stock listing
Gain Therapeutics, Inc.
Selected listing: GANX · NASDAQ · USD · US
Gain Therapeutics, Inc. (NASDAQ:GANX), Health Technology. Latest release Oct 1, 2026: Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data…
- Ticker
- NASDAQ:GANX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Gain Therapeutics, Inc.
The company focuses on developing innovative therapies for various diseases. Gain Therapeutics is committed to advancing its research and development efforts to bring new treatment options to market.
Latest news from Gain Therapeutics, Inc.
Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration
September 30, 2026
Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson’s Disease and Movement Disorders
September 28, 2026
Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference
September 17, 2026
Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference
August 25, 2026
Gain Therapeutics Reports Financial Results for Second Quarter 2026 and Provides Corporate Update
August 11, 2026
Research Gain Therapeutics, Inc.
Gain Therapeutics, Inc. company profile
View the public company page for Gain Therapeutics, Inc. on 6ix.
Gain Therapeutics, Inc. news
Read company news and market updates connected to Gain Therapeutics, Inc..
Gain Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Gain Therapeutics, Inc..